Helping patients and families make informed decisions about dementia therapies
Helping Patients, Families, and Clinicians Make Shared Decisions about Therapies for Dementia
This study is creating a helpful guide for patients, families, and doctors to make better choices about dementia treatments, especially a new drug called Lecanemab-IRMB, by understanding what people need to know about the benefits and risks of these options.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10949237 on NIH RePORTER |
What this research studies
This research focuses on developing a patient decision aid to assist patients, families, and clinicians in making informed choices about dementia therapies, particularly the newly approved drug Lecanemab-IRMB. The project will involve a needs assessment to understand the challenges faced in discussing treatment options and will utilize a user-centered approach to create effective communication tools. By facilitating shared decision-making, the research aims to ensure that patients and families are fully aware of the potential benefits and risks associated with dementia treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with Alzheimer's disease and their caregivers who are considering treatment options.
Not a fit: Patients who are not diagnosed with Alzheimer's disease or those who are not considering any dementia therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could empower patients and families to make better-informed decisions regarding dementia therapies, leading to improved satisfaction and outcomes.
How similar studies have performed: Previous research has shown that decision aids can significantly improve patient understanding and satisfaction in treatment decision-making, indicating a promising approach.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Matlock, Daniel D — University of Colorado Denver
- Study coordinator: Matlock, Daniel D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.